$INCY
INCYTE CORP

2020 Q2 Form 10-Q Financial Statement

#000155837020009164 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $688.0M $529.9M
YoY Change 29.84% 1.61%
Cost Of Revenue $33.36M $29.41M
YoY Change 13.46% 18.31%
Gross Profit $654.7M $500.5M
YoY Change 30.8% 0.78%
Gross Profit Margin 95.15% 94.45%
Selling, General & Admin $118.0M $105.9M
YoY Change 11.38% -1.93%
% of Gross Profit 18.02% 21.17%
Research & Development $286.6M $289.4M
YoY Change -0.95% -2.93%
% of Gross Profit 43.78% 57.81%
Depreciation & Amortization $12.60M $13.40M
YoY Change -5.97% -0.74%
% of Gross Profit 1.92% 2.68%
Operating Expenses $404.6M $395.3M
YoY Change 2.35% -2.66%
Operating Profit $230.8M $98.61M
YoY Change 134.02% 18.47%
Interest Expense $600.0K $316.0K
YoY Change 89.87% -20.6%
% of Operating Profit 0.26% 0.32%
Other Income/Expense, Net $4.817M $15.00M
YoY Change -67.89% 158.26%
Pretax Income $307.3M $108.7M
YoY Change 182.75% 101.21%
Income Tax $17.00M $3.400M
% Of Pretax Income 5.53% 3.13%
Net Earnings $290.3M $105.3M
YoY Change 175.64% 101.01%
Net Earnings / Revenue 42.19% 19.87%
Basic Earnings Per Share $1.33 $0.49
Diluted Earnings Per Share $1.32 $0.48
COMMON SHARES
Basic Shares Outstanding 217.5M 214.6M
Diluted Shares Outstanding 220.4M 217.5M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.589B $1.696B
YoY Change -6.27% 41.51%
Cash & Equivalents $1.327B $1.416B
Short-Term Investments $262.8M $279.6M
Other Short-Term Assets $51.60M $53.60M
YoY Change -3.73% -30.84%
Inventory $16.34M $6.500M
Prepaid Expenses
Receivables $420.2M $302.4M
Other Receivables $100.0K $300.0K
Total Short-Term Assets $2.078B $2.059B
YoY Change 0.92% 28.82%
LONG-TERM ASSETS
Property, Plant & Equipment $453.8M $339.1M
YoY Change 33.81% 26.73%
Goodwill $155.6M $155.6M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $248.7M $115.6M
YoY Change 115.14% -11.96%
Other Assets $53.27M $36.61M
YoY Change 45.51% 98.95%
Total Long-Term Assets $1.135B $889.0M
YoY Change 27.64% 11.25%
TOTAL ASSETS
Total Short-Term Assets $2.078B $2.059B
Total Long-Term Assets $1.135B $889.0M
Total Assets $3.212B $2.948B
YoY Change 8.98% 22.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.91M $66.18M
YoY Change 37.36% -12.46%
Accrued Expenses $340.9M $210.5M
YoY Change 61.96% -17.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $19.80M $800.0K
YoY Change 2375.0% -89.47%
Total Short-Term Liabilities $556.5M $367.1M
YoY Change 51.6% -0.3%
LONG-TERM LIABILITIES
Long-Term Debt $31.90M $49.50M
YoY Change -35.56% 191.18%
Other Long-Term Liabilities $42.80M $33.76M
YoY Change 26.77% -87.9%
Total Long-Term Liabilities $42.80M $33.76M
YoY Change 26.77% -88.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $556.5M $367.1M
Total Long-Term Liabilities $42.80M $33.76M
Total Liabilities $867.7M $700.4M
YoY Change 23.88% 5.46%
SHAREHOLDERS EQUITY
Retained Earnings -$1.861B -$1.670B
YoY Change 11.44%
Common Stock $4.218B $3.926B
YoY Change 7.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.345B $2.247B
YoY Change
Total Liabilities & Shareholders Equity $3.212B $2.948B
YoY Change 8.98% 22.96%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $290.3M $105.3M
YoY Change 175.64% 101.01%
Depreciation, Depletion And Amortization $12.60M $13.40M
YoY Change -5.97% -0.74%
Cash From Operating Activities $269.4M $152.9M
YoY Change 76.19% 371.91%
INVESTING ACTIVITIES
Capital Expenditures -$43.80M -$47.30M
YoY Change -7.4% 337.96%
Acquisitions
YoY Change
Other Investing Activities $600.0K $2.200M
YoY Change -72.73% -67.65%
Cash From Investing Activities -$43.20M -$45.10M
YoY Change -4.21% 1027.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.40M 9.000M
YoY Change 526.67% 60.71%
NET CHANGE
Cash From Operating Activities 269.4M 152.9M
Cash From Investing Activities -43.20M -45.10M
Cash From Financing Activities 56.40M 9.000M
Net Change In Cash 282.6M 116.8M
YoY Change 141.95% 243.53%
FREE CASH FLOW
Cash From Operating Activities $269.4M $152.9M
Capital Expenditures -$43.80M -$47.30M
Free Cash Flow $313.2M $200.2M
YoY Change 56.44% 363.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216177830
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218069218
CY2020Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2020Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2019Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2020Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
INCYTE CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000879169
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12400
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3136539
dei Entity Address Address Line1
EntityAddressAddressLine1
1801 Augustine Cut-Off
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19803
dei City Area Code
CityAreaCode
302
dei Local Phone Number
LocalPhoneNumber
498-6700
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
dei Trading Symbol
TradingSymbol
INCY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
218699085
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1326730000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1832684000
CY2020Q2 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
262556000
CY2020Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
262756000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
284870000
CY2020Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
420250000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
308809000
CY2020Q2 us-gaap Inventory Net
InventoryNet
16335000
CY2019Q4 us-gaap Inventory Net
InventoryNet
11400000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51554000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43725000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
2077625000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2481488000
CY2020Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
2583000
CY2019Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1023000
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
248731000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
133657000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
9554000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5105000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453777000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377567000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
28133000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
29058000
CY2020Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
183060000
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
193828000
CY2020Q2 us-gaap Goodwill
Goodwill
155593000
CY2019Q4 us-gaap Goodwill
Goodwill
155593000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53265000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49431000
CY2020Q2 us-gaap Assets
Assets
3212321000
CY2019Q4 us-gaap Assets
Assets
3426750000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90909000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83647000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67396000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
90706000
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
29000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
340890000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
285950000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1189000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2020Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
18588000
CY2019Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
18300000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37512000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
34044000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
556513000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
513340000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31918000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
236488000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
242956000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31917000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42799000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40130000
CY2020Q2 us-gaap Liabilities
Liabilities
867717000
CY2019Q4 us-gaap Liabilities
Liabilities
828344000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2598406000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3212321000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3426750000
CY2020Q2 us-gaap Revenues
Revenues
688043000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
218069218
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216177830
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
218000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
216000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4217911000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4044490000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12423000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15542000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1861102000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1430758000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2344604000
CY2019Q2 us-gaap Revenues
Revenues
529932000
us-gaap Revenues
Revenues
1256550000
us-gaap Revenues
Revenues
1027789000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
33364000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
29406000
us-gaap Cost Of Revenue
CostOfRevenue
60683000
us-gaap Cost Of Revenue
CostOfRevenue
51994000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
286601000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
289363000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1371888000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
559908000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117998000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105943000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
229146000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
229926000
CY2020Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6054000
CY2019Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6608000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12681000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13279000
CY2020Q2 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
13253000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
15383000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
457270000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
431320000
us-gaap Costs And Expenses
CostsAndExpenses
1689781000
us-gaap Costs And Expenses
CostsAndExpenses
855107000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
230773000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
98612000
us-gaap Operating Income Loss
OperatingIncomeLoss
-433231000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
212768000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
105318000
us-gaap Net Income Loss
NetIncomeLoss
-430344000
us-gaap Operating Income Loss
OperatingIncomeLoss
172682000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4817000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13479000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24373000
CY2020Q2 us-gaap Interest Expense
InterestExpense
600000
CY2019Q2 us-gaap Interest Expense
InterestExpense
316000
us-gaap Interest Expense
InterestExpense
1202000
us-gaap Interest Expense
InterestExpense
651000
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
72274000
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4625000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
24142000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16364000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
307264000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
108671000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-396812000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16966000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3353000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33532000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5138000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
290298000
us-gaap Net Income Loss
NetIncomeLoss
207630000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217549000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214620000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217135000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214342000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220434000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217483000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217135000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217274000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
290298000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
105318000
us-gaap Net Income Loss
NetIncomeLoss
-430344000
us-gaap Net Income Loss
NetIncomeLoss
207630000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
993000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-284000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2553000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-158000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-529000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
458000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
125000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1139000
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-220000
CY2019Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-108000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-441000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-219000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
684000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
282000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3119000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1200000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
290982000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105600000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-427225000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
208830000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2598406000
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
772538
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14619000
CY2020Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1957
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
145000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42758000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2435000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-720642000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1937721000
CY2020Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
936688
CY2020Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
175615
CY2020Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
69194000
CY2020Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1403
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
139000
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3187
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
162000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46406000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
684000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
290298000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2344604000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1925967000
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1044745
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15481000
CY2019Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
104000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40690000
CY2019Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
95000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
918000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
102312000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2085567000
CY2019Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
400292
CY2019Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
143379
CY2019Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
15191000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
282000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
105318000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2247191000
us-gaap Profit Loss
ProfitLoss
-430344000
CY2019Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1444
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40710000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
16577000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-414035000
us-gaap Profit Loss
ProfitLoss
207630000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25692000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27326000
us-gaap Share Based Compensation
ShareBasedCompensation
88816000
us-gaap Share Based Compensation
ShareBasedCompensation
81207000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8567000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-227000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
24142000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16364000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12681000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13279000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
119724000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4918000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11663000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8354000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9384000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2288000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7262000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-32243000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
38204000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
308623000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
95468000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
4536000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
83125000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
65561000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
287419000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
103970000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
309658000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
99821000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151818000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69710000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
83813000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
30672000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
387000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
409000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
24520000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
16766000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58906000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13497000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2553000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-158000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-504394000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
252252000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1833707000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1164986000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1329313000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1417238000
us-gaap Interest Paid Net
InterestPaidNet
119000
us-gaap Interest Paid Net
InterestPaidNet
119000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
24165000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6439000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
162000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14817000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8720000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2358000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
529000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
29740000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.</i>  The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Concentrations of Credit Risk.</i>  Cash, cash equivalents, marketable securities, and trade receivables are financial instruments which potentially subject us to concentrations of credit risk. The estimated fair value of financial instruments approximates the carrying value based on available market information. We primarily invest our excess available funds in </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">debt securities and, by policy, limit the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government and money market funds that meet certain guidelines. Our receivables mainly relate to our product sales and collaborative agreements with pharmaceutical companies. We have not experienced any significant credit losses on cash, cash equivalents, marketable securities, or trade receivables to date and do not require collateral on receivables.</p>
incy Credit Exposure Limitation Number Of Issuer Other Than United States Government Guaranteed Securities
CreditExposureLimitationNumberOfIssuerOtherThanUnitedStatesGovernmentGuaranteedSecurities
1
incy Credit Exposure Limitation Number Of Financial Investment Other Than United States Government Guaranteed Securities
CreditExposureLimitationNumberOfFinancialInvestmentOtherThanUnitedStatesGovernmentGuaranteedSecurities
1
CY2020Q2 incy Variable Interest Entities Number
VariableInterestEntitiesNumber
0
incy Percentage Of Medicare Part D Insurance Coverage Gap Required To Be Funded By Manufacturers
PercentageOfMedicarePartDInsuranceCoverageGapRequiredToBeFundedByManufacturers
0.70
incy Medicare Part D Insurance Coverage Gap Increase In Eligible Patient Spending Percentage
MedicarePartDInsuranceCoverageGapIncreaseInEligiblePatientSpendingPercentage
0.30
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
688043000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
529932000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256550000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1027789000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5105000
CY2020Q2 us-gaap Inventory Net
InventoryNet
16300000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2900000
us-gaap Operating Lease Cost
OperatingLeaseCost
6100000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10619000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8634000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13995000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6596000
CY2020Q2 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
25889000
CY2019Q4 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
16505000
CY2020Q2 us-gaap Inventory Net
InventoryNet
16335000
CY2019Q4 us-gaap Inventory Net
InventoryNet
11400000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
9554000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
9600000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
584213000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
499437000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
130436000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121870000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453777000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377567000
us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10059000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9343000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1189000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13956000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11854000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31917000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31918000
CY2020Q2 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
57121000
CY2019Q4 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
53779000
us-gaap Operating Lease Payments
OperatingLeasePayments
5900000
us-gaap Operating Lease Payments
OperatingLeasePayments
5400000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
400000
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P15Y2M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.036
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1300000
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
600000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3600000
us-gaap Operating Lease Cost
OperatingLeaseCost
7300000
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
200000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
2900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
6400000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
3700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
7000000.0
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
10768000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21536000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
21536000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21536000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
21536000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
86148000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46300000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
88800000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81200000
CY2020Q2 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
100000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
300000
CY2019Q2 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
100000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes valuation model
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2602376
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
79.69
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2719369
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
80.33
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9882122
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted
1953476
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled
506744
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8435390
incy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate
0.05
CY2020Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
77800000
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
73221000
CY2020Q2 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
95172000
CY2019Q4 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
88710000
CY2020Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
71085000
CY2019Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
59924000
CY2020Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
14817000
CY2019Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
12732000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10059000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9343000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
71957000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42020000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
340890000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
285950000
CY2020Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3300000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6600000
CY2019Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3100000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6000000.0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000
CY2020Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1477000
CY2019Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1288000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2934000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2550000
CY2020Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
47000
CY2019Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
86000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
93000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
169000
CY2020Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
31000
CY2019Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
61000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
61000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
120000
CY2020Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
53000
CY2019Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
62000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
107000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
107000
CY2020Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-167000
CY2019Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-46000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-334000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-112000
CY2020Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1713000
CY2019Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1421000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3407000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2818000
CY2020Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
4000000.0
CY2020Q2 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
25200000
CY2019Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
24100000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000000.0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33500000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
800000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-200000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
290298000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
105318000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-430344000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
207630000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217549000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214620000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217135000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214342000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
290298000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
105318000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-430344000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
207630000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217549000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214620000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217135000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214342000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2885000
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2863000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2932000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220434000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217483000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217135000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217274000
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5336636
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9534715
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14964275
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9590880

Files In Submission

Name View Source Status
0001558370-20-009164-index-headers.html Edgar Link pending
0001558370-20-009164-index.html Edgar Link pending
0001558370-20-009164.txt Edgar Link pending
0001558370-20-009164-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
incy-20200630.xsd Edgar Link pending
incy-20200630x10q.htm Edgar Link pending
incy-20200630x10q_htm.xml Edgar Link completed
incy-20200630xex10d1.htm Edgar Link pending
incy-20200630xex10d1001.jpg Edgar Link pending
incy-20200630xex31d1.htm Edgar Link pending
incy-20200630xex31d2.htm Edgar Link pending
incy-20200630xex32d1.htm Edgar Link pending
incy-20200630xex32d2.htm Edgar Link pending
incy-20200630_cal.xml Edgar Link unprocessable
incy-20200630_def.xml Edgar Link unprocessable
incy-20200630_lab.xml Edgar Link unprocessable
incy-20200630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending